What is the appropriate first‑line treatment and dosing for central diabetes insipidus in a comatose, mechanically ventilated patient who cannot drink?

Treatment of Central Diabetes Insipidus in Comatose, Mechanically Ventilated Patients

For a comatose, mechanically ventilated patient with central diabetes insipidus who cannot drink, initiate continuous intravenous vasopressin infusion starting at 1.5-2.5 mU/kg/hour, titrating to maintain urine output around 65 ml/100 kcal metabolized/day (approximately 1-2 ml/kg/hour), while simultaneously providing 5% dextrose in water intravenously to replace ongoing fluid losses.

Rationale for Vasopressin Infusion

In the acute, critical care setting where the patient cannot self-regulate fluid intake, continuous IV vasopressin offers distinct advantages over desmopressin (DDAVP):

• Rapid onset and offset of action allows precise titration based on real-time urine output 1
• Effect typically seen within 1-6 hours of initiation 1
• Easy dose adjustment in response to changing clinical status 1
• Proven efficacy in managing hypovolemic shock associated with acute central DI 2

The starting dose of 1.3-2.7 mU/kg/hour has been successfully used in comatose children with neurogenic diabetes insipidus, with the infusion rate adjusted according to urine flow 1.

Fluid Management Protocol

Initial Fluid Replacement

• Use 5% dextrose in water as the primary IV fluid for rehydration
• Calculate initial administration rate to avoid sodium decrease >8 mmol/L/day to prevent cerebral edema
• Never administer dextrose 5% as a bolus due to risk of rapid sodium shifts
• Target fluid rate should balance ongoing losses plus replacement of deficit over 48 hours

Monitoring Requirements

Close observation is mandatory and should include:

• Hourly urine output measurement (consider urinary catheter placement)
• Serum sodium and electrolytes every 4-6 hours initially
• Fluid balance calculations
• Body weight monitoring
• Neurological status assessment
• Blood glucose monitoring (as dextrose infusion can cause hyperglycemia with subsequent osmotic diuresis)

Dosing Algorithm

Vasopressin Titration

1. Start: 1.5-2.5 mU/kg/hour IV continuous infusion
2. Target urine output: 1-2 ml/kg/hour (or ~65 ml/100 kcal metabolized/day)
3. Adjust dose every 1-2 hours based on:
   • Urine output
   • Urine specific gravity (target >1.010)
   • Serum sodium trends

Alternative Bolus Protocol

If continuous infusion is not feasible, a dilute vasopressin bolus protocol can be used 2:

• Mix 1 unit vasopressin in 1 liter of 0.45% normal saline
• Administer boluses using formula: (urine output in ml) - 100 ml
• This approach maintained average sodium of 143.8 ± 3.2 mmol/L with consistent urine output control 2

Critical Pitfalls to Avoid

Hypernatremia Correction

• Do not correct hypernatremia too rapidly - aim for correction over 17-53 hours 1
• Target sodium levels between 135-145 mmol/L, but accept 127-151 mmol/L range during acute management 1
• Overly aggressive correction risks cerebral edema

Fluid Selection Errors

• Avoid isotonic saline as primary fluid unless patient is in hypovolemic shock requiring acute resuscitation
• After any isotonic fluid bolus, must provide sufficient free water to allow excretion of renal osmotic load
• The hypotonic urine in DI requires hypotonic IV replacement to match losses

Glucose Management

• Monitor for hyperglycemia from dextrose infusion, which can paradoxically worsen polyuria through osmotic diuresis
• Adjust dextrose concentration or add insulin if blood glucose >180 mg/dL

Transition Planning

Once the patient stabilizes and can tolerate enteral access:

• Transition to desmopressin (DDAVP) after 48-72 hours of stable vasopressin infusion 2
• Oral or sublingual DDAVP is preferred over nasal formulation for long-term management 3, 4, 5
• The oral disintegrating tablet formula improves quality of life and decreases hyponatremia incidence 4

Special Considerations

Adipsic Diabetes Insipidus

If the patient has concurrent hypothalamic injury affecting thirst centers (adipsic DI):

• This is a high-risk scenario with increased morbidity and mortality 4
• Requires prescribed daily fluid intake based on body weight
• Cannot rely on patient's thirst mechanism even after extubation
• Needs inpatient assessment to establish eunatremic weight and fluid prescription 3

Expert Consultation

Strongly recommend consultation with endocrinology or nephrology experienced in DI management, as fluid requirements are often not appreciated by general medical staff, particularly in mechanically ventilated patients who cannot communicate thirst.